- Home
- CLDI vs ERNA Comparison
CLDI vs ERNA Comparison
Compare CLDI & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- ERNA
- Stock Information
- Founded
- CLDI 2014
- ERNA 2018
- Country
- CLDI United States
- ERNA United States
- Employees
- CLDI N/A
- ERNA N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- CLDI Health Care
- ERNA Health Care
- Exchange
- CLDI Nasdaq
- ERNA Nasdaq
- Market Cap
- CLDI 15.7M
- ERNA 14.5M
- IPO Year
- CLDI N/A
- ERNA N/A
- Fundamental
- Price
- CLDI $0.40
- ERNA $0.23
- Analyst Decision
- CLDI Strong Buy
- ERNA
- Analyst Count
- CLDI 2
- ERNA 0
- Target Price
- CLDI $15.00
- ERNA N/A
- AVG Volume (30 Days)
- CLDI 202.0K
- ERNA 173.9K
- Earning Date
- CLDI 05-20-2025
- ERNA 05-23-2025
- Dividend Yield
- CLDI N/A
- ERNA N/A
- EPS Growth
- CLDI N/A
- ERNA N/A
- EPS
- CLDI N/A
- ERNA N/A
- Revenue
- CLDI N/A
- ERNA $535,000.00
- Revenue This Year
- CLDI N/A
- ERNA N/A
- Revenue Next Year
- CLDI N/A
- ERNA N/A
- P/E Ratio
- CLDI N/A
- ERNA N/A
- Revenue Growth
- CLDI N/A
- ERNA 365.22
- 52 Week Low
- CLDI $0.35
- ERNA $0.15
- 52 Week High
- CLDI $4.90
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- CLDI 36.62
- ERNA 60.91
- Support Level
- CLDI $0.40
- ERNA $0.19
- Resistance Level
- CLDI $0.46
- ERNA $0.27
- Average True Range (ATR)
- CLDI 0.04
- ERNA 0.02
- MACD
- CLDI 0.00
- ERNA 0.01
- Stochastic Oscillator
- CLDI 9.73
- ERNA 64.25
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.